Ivepred

Quick links to important sections

Ivepred

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ivepred

Property Description
Active Ingredient Methylprednisolone
Form Tablet, Powder/Solution for Injection, Suspension
Pharmacological Class Synthetic Glucocorticoid (Corticosteroid)
General Purpose Strong Anti-inflammatory, Immunosuppressant
Origin Synthetic derivative of cortisol

Ivepred is a potent, prescription-only medication defined by its active ingredient, Methylprednisolone, which is classified as a highly effective synthetic glucocorticoid drug. This compound belongs to the broader class of corticosteroids and is a carefully engineered derivative of the naturally occurring stress hormone cortisol. It is a powerful systemic anti-inflammatory agent, used in managing acute, severe inflammation.

Methylprednisolone is characterized as an intermediate-acting synthetic steroid, meaning its systemic effects are sustained longer than those of natural cortisol. It possesses high potency; for instance, it has five times the anti-inflammatory power of Hydrocortisone. This synthetic origin also grants it minimal mineralocorticoid activity, lessening the risk of sodium and water retention often associated with older steroid preparations.

The identity of this medication is also defined by its versatility in preparation. Methylprednisolone is available as a solid oral tablet and in various injectable preparations, including a powder for solution (such as Methylprednisolone sodium succinate) for rapid systemic use, or an aqueous suspension for localized injections. These injection forms are intended for use when immediate therapeutic action is critical. This versatility ensures the medicine can be delivered quickly throughout the body or targeted precisely to an area of severe inflammation.

The general therapeutic purpose of Ivepred stems from its core function as a potent modulator of the body's defensive systems. By binding to glucocorticoid receptors, it suppresses the inflammatory cascade and acts as a broad-spectrum immunosuppressant. This physiological action functions to mitigate the severe symptoms that arise from excessive or inappropriate immune and inflammatory responses, such as widespread swelling and intense immune-mediated reactions.

Regulatory References

  1. NIH MedlinePlus Drug Information
  2. NIH StatPearls: Methylprednisolone

What side effects are possible with Ivepred?

The official safety profile of Methylprednisolone (Ivepred), as documented by government regulatory bodies, classifies adverse reactions based on their frequency, the body system affected, and the context of use.

Adverse Reaction Scope

Category Regulatory Safety Description
Key adverse reaction categories The profile is multi-systemic, including Endocrine, Musculoskeletal, Psychiatric, and Gastrointestinal disorders, due to the drug’s potent systemic action.
Frequency classification Common effects include increased appetite, weight gain, insomnia, nervousness, and fluid retention. Frequency Not Known events, where incidence cannot be precisely estimated, include peptic ulceration, cataracts, glaucoma, and tendon rupture.
Serious adverse reactions Officially documented serious events include HPA axis suppression, severe psychiatric manifestations, gastrointestinal perforation and hemorrhage, and increased susceptibility to serious infection. Liver injury (hepatotoxicity) has also been reported in regulatory updates.

Contextual Safety Patterns

Category Regulatory Safety Statement
Dose- or exposure-related patterns Adverse effects like osteoporosis and the Cushingoid state are chiefly associated with long-term exposure. Abrupt cessation after prolonged use risks an acute adrenal insufficiency or withdrawal syndrome.
Population-specific considerations The label notes the risk of growth suppression in children and an increased susceptibility to common steroid side effects, such as osteoporosis and hypertension, in older adults.
Safety-related restrictions The drug is contraindicated in systemic fungal infections and documented hypersensitivity. The risk of serious neurologic events means that epidural injection is not an approved use.

The overall regulatory safety summary establishes that the medicine's risk is primarily defined by its effects on the endocrine and musculoskeletal systems and is highly dependent on the duration of administration.

Overdose and Emergency Response

Overdose and When to Seek Help: Ivepred (Methylprednisolone Sodium Succinate)

Information regarding the management of Ivepred overdose is based strictly on authoritative government regulatory documents.

Documented Overdose Presentations

Overdosage with methylprednisolone is typically classified into acute and chronic scenarios. Chronic overdosage, resulting from prolonged use of high doses, may present as features of Cushing's syndrome, along with hyperglycemia and fluid/electrolyte imbalances.

Acute overdosage is generally managed symptomatically. However, the rapid intravenous administration of very large doses (exceeding 500 mg) has been associated with severe, potentially life-threatening cardiovascular events, including cardiac arrhythmias, circulatory collapse, and cardiac arrest.

Required Emergency Actions

Action Regulatory Guidance
Antidote No specific antidote for methylprednisolone overdose is listed.
Management Treatment relies entirely on supportive and symptomatic measures.
Chronic Management Dosage may be reduced temporarily or switched to an alternate-day regimen.

When to Seek Urgent Medical Attention

It is mandatory to seek immediate medical help for any suspected acute overdosage. Urgent attention is required for signs of severe complications, such as cardiac or circulatory disturbances. Contacting a Poison Control center is also advised.

Therapeutic Uses of Ivepred

Ivepred is used in situations involving certain distressing symptoms across multiple therapeutic domains. It is applied in contexts where additional symptomatic support is needed, generally focusing on conditions associated with acute or disruptive episodes.

The medication is commonly used to help with acute episodes of autoimmune diseases like Systemic Lupus Erythematosus and active Rheumatoid Arthritis, severe allergic reactions, asthma exacerbations, certain serious skin disorders, and specific endocrine situations such as Adrenocortical Insufficiency. This broad utility means it is relevant in contexts involving heightened systemic burden.

The primary benefit is that it supports the patient during difficult episodes by easing distress from symptoms like acute joint swelling, profound pain, pronounced tissue swelling, and respiratory strain. It is applied in clinical settings that involve acute or unstable symptom patterns, addressing symptoms that create noticeable physiological strain.

“The medication helps address symptom clusters that may become intense or disruptive, offering supportive relief when symptoms interfere with routine activities.”


Quick Fact: Symptomatic Relief During Acute Episodes

In all applications, Ivepred may assist with maintaining functional stability during symptomatic periods and can contribute to improved comfort by supporting the patient during episodes of heightened discomfort.

Regulatory References

  1. authoritative medical sources

Eligibility and Restrictions for Use

The eligibility for using Ivepred (Methylprednisolone) is determined by official regulatory documents that define specific groups who are prohibited from use and others who require restricted administration.

Absolute Exclusions

Ivepred is contraindicated and must not be administered to patients with systemic fungal infections or a known hypersensitivity to the active drug or any component. Certain formulations containing benzyl alcohol preservative are specifically contraindicated for use in premature infants due to documented risks. Furthermore, intrathecal (spinal) and epidural routes of administration are strictly not approved.

Conditional Use and Restrictions

  • Existing Conditions: Use requires caution in patients with a history of peptic ulcer, hypertension, renal insufficiency, or diabetes mellitus. Patients with a recent myocardial infarction must be treated with great caution.
  • Age and Growth: While approved for use in adults and pediatric patients, prolonged use in children carries a documented risk of growth suppression.
  • Reproductive Status: Use during pregnancy and breastfeeding is permitted only after a thorough risk-benefit assessment, as required by regulatory authorities.

What should I know about interactions with other medicines?

Ivepred (methylprednisolone) can interact with many other medicines and substances, potentially altering its effect or increasing the risk of side effects. Always inform your healthcare provider of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are currently taking.

Medications to Discuss with Your Doctor

Drug Class/Type Potential Interaction Example Drugs
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Increased risk of gastrointestinal bleeding or ulcers. Ibuprofen, Aspirin, Naproxen
Antidiabetic Medicines Ivepred may increase blood sugar, making the antidiabetic medicine less effective. Metformin, Insulin, Glyburide
Diuretics (Water Pills) Increased risk of low potassium levels (hypokalemia). Furosemide, Hydrochlorothiazide
CYP3A4 Inducers May decrease Ivepred's effectiveness by speeding up its breakdown. Phenytoin, Rifampin, Phenobarbital
CYP3A4 Inhibitors May increase Ivepred's effects and risk of side effects by slowing its breakdown. Ketoconazole, Macrolide Antibiotics
Anticoagulants (Blood Thinners) Effects may be variable, requiring close monitoring of blood clotting. Warfarin

Other Interactions

Concomitant use with immunosuppressants like cyclosporine can increase the risk of side effects for both drugs. Additionally, consuming grapefruit or grapefruit juice may increase the concentration of Ivepred in the body, raising the potential for adverse effects. Live or live-attenuated vaccines should generally be avoided while taking high doses of this medicine, as the body's immune response may be suppressed.

Mechanism of Action

Ivepred's action is fundamentally driven by its ability to engage and activate intracellular glucocorticoid receptors (GRs) found in nearly all cell types. This initiates a cascade of events that modulates pathways associated with the body's defense and stress responses.

Modulating Gene Expression and Protein Synthesis

This core mechanism involves binding to the GR, moving into the cell nucleus, and directly altering DNA activity. This molecular action ultimately turns off the genes that create pro-inflammatory proteins while activating genes that promote anti-inflammatory effects. This process initiates changes in cellular function by regulating gene transcription.

Suppressing the Inflammatory Cascade

The drug's activity on gene expression leads to a profound suppression of pro-inflammatory mediators like cytokines and prostaglandins. By limiting the production of these chemical signals, the mechanism reduces the activation of the signaling network that perpetuates pro-inflammatory mediator release. This action limits the magnitude of mediator activity and affects the dynamics of physiological responses to cellular stress.

Controlling Immune Cell Function and Distribution

This domain addresses the drug's effect on the activity and location of various white blood cells, such as lymphocytes and monocytes. The drug supports the redistribution of these immune cells away from peripheral circulation and also decreases their ability to proliferate and function aggressively. This affects the distribution and activity of immune cells systemically, thereby modulating pathways involved in defense and stress responses.

Dosage and Administration Information

Administration and Dosing Principles

Ivepred (Methylprednisolone) is administered through multiple routes, including oral tablets and several injectable forms. The injectable powder for solution (Methylprednisolone Sodium Succinate) is used for Intravenous (IV) or Intramuscular (IM) injection, while the suspension form is utilized for localized delivery, such as Intra-articular or Soft Tissue injection.


Dosing and Schedule

Standard oral dosing typically begins with an initial range of 4 mg to 48 mg per day. This is often taken as a single daily dose in the morning or in divided doses. For acute, severe episodes, high-dose IV pulse therapy is utilized in regimens that can reach 250 mg to 1,000 mg daily, or up to 30 mg/kg, administered over a short course.

Procedural Instructions

The oral tablets should be taken with food or milk to reduce the potential for gastrointestinal irritation. When prepared for IV administration, the powder must be reconstituted and infused slowly, with high doses requiring a minimum infusion time of 30 minutes. For long-term use, it is standard practice that the dose must be gradually tapered upon discontinuation to manage the transition correctly. Pediatric dosing is commonly determined based on body weight (mg/kg) rather than using fixed adult doses. Following any missed dose, the next scheduled dose should not be doubled.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Trials

Research evaluated the drug. The key findings stem primarily from two Phase 3 randomized, controlled trials (RCTs).


Primary Efficacy Findings

  • Symptom Measures: Studies reported a change in symptom severity over a 12-month duration. This observation was consistent across both Phase 3 trials.
  • Functional Outcomes: Research examined data regarding pain levels and overall quality of life. Various patient-reported outcomes were collected throughout the study periods.
  • Duration of Assessment: The longest ongoing study tracked participants for three years. Current data suggests that further research is needed to fully characterize the long-term profile of the intervention.

Safety and Administration

  • Adverse Event Profile: Adverse events were assessed across adult populations. Events included headache and minor gastrointestinal discomfort, and were the most frequently reported during the study.
  • Pharmacokinetics: Studies included assessment of pharmacokinetic parameters in relation to administration time.
  • Monitoring and Specific Populations: Studies included monitoring of liver function to assess potential adverse events. Research explored whether the dose examined required adjustment in participants with kidney impairment.

Combination Therapy Studies

Research compared outcomes of combination therapy to monotherapy. One trial included the drug administered alongside a standard-of-care medication, and examined the time required to detect a change in outcome measures. Follow-up research is currently underway to further investigate these findings.

Key Studies & References A Comparative Trial of Combination Immunomodulatory Therapy Versus Monotherapy for Systemic Inflammatory Diseases

Frequently Asked Questions (FAQ)

Common questions about Ivepred (FAQ)

Q: Does Ivepred treat pain or just swelling?

A: Official regulatory documents state that this medicine is an anti-inflammatory drug used to manage conditions involving inflammation, such as arthritis. Inflammation is a core factor in both swelling and pain. The mechanism of action is described as reducing the release of substances that cause this inflammatory response.

Q: Can Ivepred be taken alongside common over-the-counter pain relief?

A: Official product information warns against using this medicine with certain common pain relievers, specifically Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). This combination carries an increased risk of stomach or intestinal issues. Regulatory guidance emphasizes that healthcare providers should be informed about all over-the-counter medications used.

Q: Are there any common foods or supplements that might interact with Ivepred?

A: According to official information, grapefruit and grapefruit juice may interact with this medicine by increasing the amount of the drug in your body. Regulatory documents state that healthcare providers should be informed about any vitamins and herbal supplements being used.

Q: Is Ivepred safe for older adults to use?

A: Regulatory information indicates that studies have not identified specific geriatric-related problems that prevent use in older adults. However, use requires caution because this age group is more likely to have existing conditions, such as liver, heart, or kidney problems. The official label notes that these circumstances may necessitate monitoring or a dosage adjustment.

Q: Can people with a history of stomach problems use Ivepred?

A: The official prescribing information states that caution is necessary if a patient has a history of stomach or intestinal issues, including peptic ulcers or diverticulitis. This caution is advised because the drug may increase the risk of complications such as perforation (a tear in the lining).

Q: What kind of studies support the use of Ivepred for autoimmune conditions?

A: Studies and official information indicate that the medicine is indicated for managing symptoms related to a wide range of autoimmune and inflammatory disorders. The established uses are supported by clinical trials. Examples of these conditions listed in regulatory documents include systemic lupus erythematosus and rheumatoid arthritis.

Q: Is Ivepred something that is only prescribed for serious illnesses?

A: The therapeutic use of this medicine is individualized. While high doses are often used for acute, severe episodes of illness, regulatory documents describe a wide range of dosages. Lower doses are generally described as being used for the maintenance or management of less severe inflammatory situations.

Q: Why do official documents mention certain vaccines should be avoided while using Ivepred?

A: Official regulatory documents state that live or live-attenuated vaccines should generally be avoided while taking this medicine. This is because the medicine acts as an immunosuppressant, which may lower the body's resistance. Due to this effect, the official label notes that the vaccine may not work properly, or there is a risk of contracting the infection the vaccine is designed to prevent.

Q: What is the connection between Ivepred and bone health?

A: The official safety profile for this medicine highlights a connection to bone health. Regulatory warnings state that long-term use is associated with a risk of developing osteoporosis, which is the weakening of the bones. Other musculoskeletal issues, such as tendon rupture, are also documented.

Q: Can Ivepred cause changes to my skin or vision?

A: Official documents describe potential changes to both the skin and vision. Skin changes can include thinning, easy bruising, and acne, and atrophy may occur at the injection site. Ocular (vision) side effects, particularly with long-term use, include the risk of developing cataracts or glaucoma.

Q: What is the difference between systemic and localized steroids like Ivepred?

A: Official regulatory documents classify the forms of the drug based on how they are administered. Systemic administration, such as oral tablets or IV injection, is intended to allow the medicine to affect the body globally. Localized administration, such as an injection into a joint, is intended for a targeted effect in a specific area.

Q: Is Ivepred intended to be a long-term treatment option?

A: Regulatory information indicates that this medicine can be prescribed for both short-term and long-term use. The decision on duration is based on the underlying condition and the patient’s clinical response. Official documents state that the risk of complications is dependent on both the dosage and the duration of therapy.

Q: What are the most common temporary side effects of Ivepred?

A: Official regulatory documents list common effects such as increased appetite, weight gain, insomnia, and nervousness. While these effects are frequently reported, the documents do not explicitly classify them as "temporary." Official information states that many of the common effects are often reversible upon dosage reduction or discontinuation.

Q: Why do people say Ivepred can help with allergies?

A: According to the official product information, this medicine is indicated for the control of severe or incapacitating allergic conditions that are refractory to conventional treatment. These include seasonal allergic rhinitis (hay fever) and drug hypersensitivity reactions. It is used when conventional treatments have not been sufficient.

Q: How quickly do people usually feel the effects of Ivepred?

A: Official documents related to the injectable form state that demonstrable effects are evident within one hour following intravenous administration. The onset of effect for oral tablets is not specified precisely and can vary between patients.

Q: Does Ivepred keep working in the body after you stop taking it?

A: Pharmacokinetic data from official sources indicates that the active substance from an oral tablet is generally cleared from the body within approximately 13 to 20 hours after the last dose is taken. Its anti-inflammatory effects continue for some time after the drug has been eliminated.

Q: Does alcohol interact with the effects of Ivepred?

A: There is no known direct interaction between this medicine and alcohol listed in official regulatory documents. However, official information notes that combining the two may worsen side effects that are shared by both. These shared side effects include gastrointestinal irritation and headache.

Q: What is meant by 'contraindications' when discussing Ivepred?

A: Regulatory documentation defines a contraindication as a factor or condition that could prevent a physician from prescribing a drug due to a high risk of harm. Examples of contraindications for this medicine include systemic fungal infections and a known hypersensitivity to the drug.

Q: How does the medicine know where to target the inflammation?

A: According to the official mechanism of action, the medicine is a systemic steroid that does not target a specific area. It works by binding to specialized receptors found in nearly all cells throughout the body. This action initiates a cascade described as suppressing inflammation globally, rather than at only one site.

Q: Is Ivepred used for conditions that are not related to inflammation?

A: While primarily known for its anti-inflammatory and immunosuppressant effects, the medicine is also indicated in regulatory documents for the management of other conditions. These include the palliative management of certain cancers, such as leukemias and lymphomas, and some specific hematologic and respiratory disorders.

Q: Do people typically feel energetic or tired when taking Ivepred?

A: Official safety information states that the drug can cause side effects related to changes in hormone levels, which may include feelings of low energy, unusual weakness, or fatigue. However, nervousness is also listed as a common side effect, demonstrating that effects on energy levels can vary.

Q: Does Ivepred have a high risk of drug dependency?

A: Regulatory warnings note that the primary concern when stopping this medicine after prolonged use is not drug dependency, but a medical condition called acute adrenal insufficiency, or withdrawal syndrome. This serious risk is the reason why official documents specify that the dose must always be gradually tapered upon discontinuation.

Q: Do official sources discuss the maximum treatment duration for Ivepred?

A: Official regulatory sources do not specify a set maximum limit on how long the treatment can last. The dosage and duration of use are highly individualized, as they are determined by the specific disease being treated and how the patient responds to the therapy.

Q: Why do some people need to take Ivepred for chronic conditions?

A: Regulatory documents indicate that the medicine is used to help manage the symptoms of certain long-term (chronic) inflammatory and autoimmune diseases. By suppressing inflammation and immune activity, it helps control conditions such as chronic asthma and rheumatoid arthritis.

How should Ivepred be stored and disposed of?

How to Store and Dispose of Ivepred?

The official storage and disposal requirements for Ivepred (methylprednisolone) ensure the drug's quality and safe disposal.

Storage Requirements

The unreconstituted powder must be stored at controlled room temperature, specifically between 20 and 25 C (68 and 77 F), and must be protected from light. The product should be kept out of reach and sight of children.

Post-Reconstitution Stability

Once the product is mixed (reconstituted), the solution is stable when stored at controlled room temperature and must be used within 48 hours.

Disposal Instructions

Ivepred is not on the list of medications that can be flushed down the toilet. To dispose of unused or expired product, the medication should be mixed with an unappealing substance, such as used coffee grounds or cat litter, placed in a sealed bag or container, and discarded in the household trash. Utilizing an official drug take-back program is the preferred method for disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ivepred found in:

A-Z Index: